Phase I/II study of radiotherapy in combination with local injection of H2O2 (KORTUC II) for advanced or relapsed cancer

Between January 2009 and June 2011, 29 patients with advanced or relapsed cancer were treated with radiotherapy and local injection of H2O2 as a radiation sensitizer (KORTUC II) in our Clinic. They included head and neck cancer (n=8), breast cancer (n=7), GI tract cancer (n=6) and others (n=8). The 10/29 patients had a history of local irradiation at the previous hospitals. The 4/29 patients stopped during the treatment, 3 of them were due to the poor general conditions not due to this treatment, and only one was due to local pain. This therapy was tolerable for almost patients. We analysed the local response of twelve patients irradiated more than BED2.050 Gy. One patient with breast DCIS had stable disease at 1 month after the therapy. The local effectiveness of 11/12 patients was PR. Radiotherapy with KORTUG II is safe and effective, it may become a main treatment for radio-resistant tumor. (author)